FDA approves once-daily Kaletra.
D015492:AIDS Serodiagnosis; D000284:Administration, Oral; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017277:Drug Approval; D042241:Early Diagnosis; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D061466:Lopinavir; D008297:Male; D011379:Prognosis; D011744:Pyrimidinones / Q000008:administration & dosage*; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States
D011744:Pyrimidinones; D061466:Lopinavir